Cost ‐effectiveness of revascularization in patients with intermittent claudication

ConclusionThe costs associated with revascularization together with BMT in patients with intermittent claudication were about four times higher than those of BMT alone. The incremental cost ‐effectiveness ratio of revascularization was within the accepted threshold for public willingness to pay according to the Swedish National Guidelines, but exceeded that of the UK National Institute for Health and Care Excellence guidelines.

Source: British Journal of Surgery - October 25, 2018 Category: Surgery Authors: H. Djerf, M. Falkenberg, L. Jiveg ård, H. Lindgren, M. Svensson, J. Nordanstig Tags: Randomized clinical trial Source Type: research